Skip to main content
. 2014 Dec 5;5(23):11847–11856. doi: 10.18632/oncotarget.2663

Figure 5. Model for intracellular signaling underlying the induction of apoptosis by cetuximab and patritumab in colorectal cancer cells.

Figure 5

(A) DiFi colorectal cancer cells treated with cetuximab alone. (B) DiFi cells that stably overexpress heregulin (DiFi-HRG cells) are resistant to cetuximab as a result of HER2-HER3 heterodimerization and AKT activation induced by heregulin. (C) Patritumab abrogates cetuximab resistance mediated by the heregulin autocrine loop in DiFi-HRG cells.